Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Canadian Packaging Materials and Machinery End-Use Market #3 - Pharmaceutical

The manufacturing of pharmaceutical products in Canada is similar to that in the U.S., and demand for packaging machinery is comparable, with slow but steady growth at 1% annually.

Canadian Pharmaceutical Market
Canadian Pharmaceutical Market

The Canadian pharmaceutical industry, which includes branded and generic prescription drugs, as well as OTC products, is about C$11.5 billion, according to PMMI Business Intelligence’s new report “The Market for Packaging Machinery in Canada 2018.

Canadian generics have gained share, due to large Canadian manufacturers such as Apotex and Pharmasciences’ focused efforts. Generics have consistently been relatively more expensive, thus boosting industry revenue.

The main engine for growth is increasing use of biologics. A second potential area for growth is the legalized cannabis industry. Demands for anti-counterfeiting features in packaging will also likely increase, due to the Drug Supply Chain Security Act (DSCSA).

Canadian pharma packaging is more functional than marketing driven, with the exception of OTC. Rigid plastic containers are most common, both for pills and liquids. Paperboard is used for folding cartons for secondary packaging and blister packs.

Download the FREE executive summary of this report, or, PMMI Members can download the entire report for free here.

Source: PMMI Business Intelligence, “The Market for Packaging Machinery in Canada 2018

The Canadian pharmaceutical industry, which includes branded and generic prescription drugs, as well as OTC products, is about C$11.5 billion, according to PMMI Business Intelligence’s new report “The Market for Packaging Machinery in Canada 2018.

Canadian generics have gained share, due to large Canadian manufacturers such as Apotex and Pharmasciences’ focused efforts. Generics have consistently been relatively more expensive, thus boosting industry revenue.

The main engine for growth is increasing use of biologics. A second potential area for growth is the legalized cannabis industry. Demands for anti-counterfeiting features in packaging will also likely increase, due to the Drug Supply Chain Security Act (DSCSA).

Canadian pharma packaging is more functional than marketing driven, with the exception of OTC. Rigid plastic containers are most common, both for pills and liquids. Paperboard is used for folding cartons for secondary packaging and blister packs.

Download the FREE executive summary of this report, or, PMMI Members can download the entire report for free here.

Source: PMMI Business Intelligence, “The Market for Packaging Machinery in Canada 2018

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report